Alaunos Therapeutics Inc (TCRT)
2.39
+0.07
(+3.02%)
USD |
NASDAQ |
Nov 22, 16:00
2.355
-0.04
(-1.46%)
After-Hours: 20:00
Alaunos Therapeutics Total Assets (Quarterly): 3.55M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.55M |
June 30, 2024 | 4.678M |
March 31, 2024 | 6.037M |
December 31, 2023 | 8.263M |
September 30, 2023 | 19.44M |
June 30, 2023 | 27.93M |
March 31, 2023 | 48.64M |
December 31, 2022 | 64.94M |
September 30, 2022 | 67.34M |
June 30, 2022 | 73.93M |
March 31, 2022 | 84.99M |
December 31, 2021 | 94.86M |
September 30, 2021 | 113.76M |
June 30, 2021 | 106.76M |
March 31, 2021 | 128.47M |
December 31, 2020 | 146.34M |
September 30, 2020 | 165.89M |
June 30, 2020 | 181.68M |
March 31, 2020 | 198.28M |
December 31, 2019 | 109.11M |
September 30, 2019 | 117.95M |
June 30, 2019 | 73.17M |
March 31, 2019 | 83.50M |
December 31, 2018 | 95.05M |
September 30, 2018 | 66.80M |
Date | Value |
---|---|
June 30, 2018 | 76.38M |
March 31, 2018 | 87.46M |
December 31, 2017 | 105.61M |
September 30, 2017 | 116.56M |
June 30, 2017 | 126.81M |
March 31, 2017 | 94.49M |
December 31, 2016 | 106.35M |
September 30, 2016 | 117.12M |
June 30, 2016 | 128.01M |
March 31, 2016 | 141.68M |
December 31, 2015 | 153.72M |
September 30, 2015 | 173.36M |
June 30, 2015 | 124.04M |
March 31, 2015 | 131.65M |
December 31, 2014 | 45.24M |
September 30, 2014 | 49.11M |
June 30, 2014 | 55.35M |
March 31, 2014 | 63.32M |
December 31, 2013 | 71.75M |
September 30, 2013 | 29.48M |
June 30, 2013 | 45.60M |
March 31, 2013 | 63.35M |
December 31, 2012 | 83.40M |
September 30, 2012 | 105.64M |
June 30, 2012 | 122.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.55M
Minimum
Sep 2024
198.28M
Maximum
Mar 2020
82.75M
Average
79.46M
Median
Total Assets (Quarterly) Benchmarks
Microbot Medical Inc | 5.208M |
SELLAS Life Sciences Group Inc | 26.50M |
Galectin Therapeutics Inc | 28.97M |
Oragenics Inc | 5.204M |
Anavex Life Sciences Corp | 141.54M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.826M |
Shareholders Equity (Quarterly) | 2.724M |